Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II

Clinical trial NCT01304238 · COMPLETED

Trial details

NCT number: NCT01304238
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Acute HIT II (Heparin-induced Thrombocytopenia Type II)

Start date: 2009-02-01
Primary completion: 2010-01-01
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.